Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life - - BioPharm International

ADVERTISEMENT

Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life



Peter Sprinz
PhD, Research Scientist,
Manufacturing Science & Technology—Statistics
Eli Lilly and Company

Add this Podcast feed to your media player



Using Stability Models to Predict Drug Characteristics at the End of Shelf Life

Listen to this interview with Peter Sprinz, PhD, a senior research scientist at Eli Lilly, to learn about using stability models to predict drug characteristics at the end of shelf life. Listen to hear how Lilly has implemented such models, and what they have gained by doing so.



Related Links
Characterizing the Formulation Design Space
Best Practices for Formulation and Manufacturing of Biotech Drug Products
Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients

Click here to go to the main podcast page >>>

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines

Click here